Sawai Group Holdings Co., Ltd. (TYO:4887)
Japan
· Delayed Price · Currency is JPY 1,779.00
+12.50 (0.71%)
May 30, 2025, 1:44 PM JST
Sawai Group Holdings Revenue
In the fiscal year ending March 31, 2025, Sawai Group Holdings had annual revenue of 189.02B JPY with 6.88% growth. Sawai Group Holdings had revenue of 45.82B in the quarter ending March 31, 2025, with 12.28% growth.
Revenue
189.02B
Revenue Growth
+6.88%
P/S Ratio
1.08
Revenue / Employee
54.29M
Employees
3,482
Market Cap
203.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 189.02B | 12.16B | 6.88% |
| Mar 31, 2024 | 176.86B | -23.48B | -11.72% |
| Mar 31, 2023 | 200.34B | 6.53B | 3.37% |
| Mar 31, 2022 | 193.82B | 6.60B | 3.52% |
| Mar 31, 2021 | 187.22B | 4.68B | 2.56% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Daiichi Sankyo Company | 1,886.26B |
| Takeda Pharmaceutical Company | 4,581.55B |
| HOYA Corporation | 869.37B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |